Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

A Pilot Study of Exjade (Deferasirox) As Monotherapy in Higher Risk MDS or Acute Myeloid Leukemia

James K. Mangan, MD PhD, Imran Ajmal, MBBS, Noelle V. Frey, MD, Elizabeth O. Hexner, MD, Alison W. Loren, MD MSCE, Martin Carroll, MD, Selina M. Luger, MD FRCPC

Blood (2019) 134 (Supplement_1): 5155.

https://doi.org/10.1182/blood-2019-131668

Published: 2019

Journal Articles

Combined Modality Low-Dose Radiation Therapy (2 Gy x 2) and Single-Agent Rituximab Immunotherapy in the Treatment of Indolent Non-Hodgkin Lymphoma

Samantha Brocklehurst, Neil Desai, MD MHS, Jennifer L Shah, MD, Syed Rizvi, MD, Praveen Ramakrishnan Geethakumari, MD, Kiran A Kumar, MD MBA

Blood (2019) 134 (Supplement_1): 5262.

https://doi.org/10.1182/blood-2019-131246

Published: 2019

Journal Articles

The Lysine-Specific Demethylase 1 (LSD1) Inhibitor Tranylcypromine (TCP) in Combination with ATRA Is Tolerable and Has Anti-Leukemic Activity in Adult Patients with Relapsed/Refractory AML and MDS

Justin M Watts, MD, Terrence J Bradley, MD, Amber Thomassen, MA, MSN, Yvonne Trang Dinh, BS, Dalissa Tejera, MSN, Kristen Englund, Sorab Boga, MPH, Randy Astaiza, BS, Charles J Chen, MPH, Malika Abdur-Rahman, BS, MSED, Marinescu Ion, CCRC, FMG, Aymee Perez, PhD, Masoumeh Tayari, PhD, Lluis Morey, PhD, Maria E. Figueroa, MD, Ramin Shiekhattar, PhD, Arthur Zelent, PhD, Ronan Swords, MD PhD

Blood (2018) 132 (Supplement 1): 2721.

https://doi.org/10.1182/blood-2018-99-115411

Published: 2018

Journal Articles

Longitudinal Sensitivity of the MD Anderson Symptom Inventory for Acute Myeloid Leukemia

Loretta A. Williams, PhD MSN, BSN, BA, Ting Yu Chen, PhD, Dimitrios P. Kontoyiannis, MD, Jessica R. Galloway-Pena, PhD, Pranoti Sahasrabhojane, MS, Samuel A. Shelburne, MD PhD, Tamara E. Lacourt, PhD, Cobi J. Heijnen, PhD, Qiuling Shi, PhD

Blood (2018) 132 (Supplement 1): 4825.

https://doi.org/10.1182/blood-2018-99-113167

Published: 2018

Journal Articles

Patient-Reported and Neurocognitive Outcomes in Patients Treated with Axicabtagene Ciloleucel

Heather S.L. Jim, PhD, Aasha I. Hoogland, PhD, Aaron Collier, Margaret Booth-Jones, PhD, Michael D. Jain, MD PhD, Frederick L. Locke, MD

Blood (2018) 132 (Supplement 1): 2289.

https://doi.org/10.1182/blood-2018-99-111711

Published: 2018

Journal Articles

Safety and Tolerability of PF-04447943 across a Clinical Trial Program Including 277 Patients

Robert J Charnigo, MS, Beesan Tan, PhD, Denis Rybin, PhD, Debra D Pittman, MS, Krupa M. Sivamurthy, MBBS, MD, David Beidler, PhD, Nicholas Clarke, PhD

Blood (2017) 130 (Supplement 1): 3558.

https://doi.org/10.1182/blood.V130.Suppl_1.3558.3558

Published: 2017

Journal Articles

Long-Term Morbidity Associated with Chronic Graft Vs. Host Disease (cGvHD) - a Blood or Marrow Transplant Survivor Study (BMTSS)

Mukta Arora, MD, Yanjun Chen, Jessica Wu, BA, Lindsey Hageman, MPH, Liton F. Francisco, BS, Emily Ness, MPH, Mariel Parman, MPH, Michelle Kung, MA, Alysia Bosworth, BA, Manju Nayar, Ravi Bhatia, MD, Stephen J. Forman, MD FACP, Daniel J. Weisdorf, MD, Saro H. Armenian, DO,MPH, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 336.

https://doi.org/10.1182/blood.V130.Suppl_1.336.336

Published: 2017

Journal Articles

Idiopathic Hemochromatosis Presenting As a Sicca Syndrome. A Case Report and Review of the Literature

Bilawal Ahmed, MD, Beenish Zulfiqar, MD

Blood (2017) 130 (Supplement 1): 4757.

https://doi.org/10.1182/blood.V130.Suppl_1.4757.4757

Published: 2017

Journal Articles

Symptom Burden of Busulfan and Melphalan Versus Melphalan Alone for Multiple Myeloma

Loretta A. Williams, PhD MSN, BSN, BA, Muzaffar H. Qazilbash, MD, Qiuling Shi, MD PhD, Qaiser Bashir, MD MBBS, Huei K. Lin, MS, Charles S. Cleeland, PhD, Richard E. Champlin, MD

Blood (2017) 130 (Supplement 1): 681.

https://doi.org/10.1182/blood.V130.Suppl_1.681.681

Published: 2017

Journal Articles

A Drug-Drug Interaction Study of Ibrutinib with Moderate and Strong CYP3A Inhibitors in Patients with B-Cell Malignancy

Jan de Jong, PhD, Peter Hellemans, MD, Severijn De Wilde, Daniel Patricia, Tara Masterson, Georgii Manikhas, MD PhD, Alexander Myasnikov, MD PhD, Dzhelil Osmanov, MD, Raul Cordoba, MD PhD, Carlos Panizo, Loeckie de Zwart, PhD, Jan Snoeys, PhD, Vijay Chauhan, PhD, James Jiao, PhD, Juthamas Sukbuntherng, PhD, Daniele Ouellet, PhD

Blood (2016) 128 (22): 3964.

https://doi.org/10.1182/blood.V128.22.3964.3964

Published: 2016

Journal Articles

Challenges of Assessing Symptom Burden in Patients with Haematological Malignancies

Tatyana Ionova, PhD, Tatyana Nikitina, MD PhD

Blood (2016) 128 (22): 2369.

https://doi.org/10.1182/blood.V128.22.2369.2369

Published: 2016

Journal Articles

A Randomized Phase 2 Placebo Controlled Trial of Clobetasol Rinse for Treatment of Oral Chronic Graft-Versus-Host Disease

Jacqueline W. Mays, DDS, MHSc, PhD, Lauren M. Curtis, MD, Carol Bassim, DMD, MS, Seth M. Steinberg, PhD, David Venzon, PhD, Jeremy J. Rose, MS, Monica Cho, Christopher G. Kanakry, MD, Fahd Yazdanie, Daniele Avila, NP, Kristin Baird, MD, Jennifer Hsu, RN, Licia Masuch, George Grimes, RPh, Judith Starling, RPh, Daniel H. Fowler, MD, Ronald E. Gress, MD, Fran T. Hakim, PhD, Steven Z. Pavletic, MD

Blood (2016) 128 (22): 826.

https://doi.org/10.1182/blood.V128.22.826.826

Published: 2016

Journal Articles

Symptom Burden, Quality of Life, and Distress in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy: Results of a Prospective Electronic Patient-Reported Outcomes Study

Thomas W. LeBlanc, MD MA, Steven P Wolf, MS, Areej El-Jawahri, MD, Debra M Davis, RN, MSEd, Susan C Locke, PhD, Amy Abernethy, MD PhD

Blood (2015) 126 (23): 4496.

https://doi.org/10.1182/blood.V126.23.4496.4496

Published: 2015

Journal Articles

Phase 1b/2 Study of the Efficacy and Safety of Sonidegib (LDE225) in Combination with Ruxolitinib (INC424) in Patients with Myelofibrosis

Vikas Gupta, MD FRCP, FRCPath, Claire N. Harrison, Hans Hasselbalch, MD, Lisa Pieri, MD PhD, Steffen Koschmieder, MD, Francisco Cervantes, Weichao Bao, PhD, Stacey Kalambakas, MD, Edric Atienza, MSHS, Prashanth Gopalakrishna, MBBS, MRCS, Florian H. Heidel, MD

Blood (2015) 126 (23): 825.

https://doi.org/10.1182/blood.V126.23.825.825

Published: 2015

Journal Articles

A Patient-Reported Outcome Measure for Symptoms and Symptom Burden of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Loretta A. Williams, PhD APRN, Araceli Garcia-Gonzalez, MD PhD, Hycienth O. Ahaneku, MBBS, DrPH, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Tito R. Mendoza, PhD, Qiuling Shi, PhD, Gautam Borthakur, MD, Jan A. Burger, MD, Elias J. Jabbour, MD, Koichi Takahashi, MD, Huei K. Lin, MS, Achala Limaye, BS, Charles S. Cleeland, PhD

Blood (2015) 126 (23): 2094.

https://doi.org/10.1182/blood.V126.23.2094.2094

Published: 2015

Journal Articles

Retrospective Analysis to Correlate Impact of Symptom Burden and Quality of Life to Treatment Outcome with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Chronic Phase

Binsah George, MD, Williams Lori, Quiling Shi, MD PhD, Talha Badar, MBBS,FCPS, Susan O'Brien, MD, Elias Jabbour, MD, Guillermo Garcia-Manero, MD, Nitin Jain, MD, Farhad Ravandi, MBBS, Gautam Borthakur, MD, William Wierda, MD PhD, Charles S. Cleeland, PhD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD

Blood (2014) 124 (21): 4548.

https://doi.org/10.1182/blood.V124.21.4548.4548

Published: 2014

Journal Articles

Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Loretta A. Williams, PhD RN, Hycienth Ahaneku, MBBS, MPH, Jorge E. Cortes, Guillermo Garcia Manero, MD, Hagop M. Kantarjian, MD, Qiuling Shi, PhD, Huei-Kai Lin, Achala R. Limaye, BS, Charles S. Cleeland, PhD

Blood (2014) 124 (21): 2652.

https://doi.org/10.1182/blood.V124.21.2652.2652

Published: 2014

Journal Articles

Zinc Deficiency In Patients Adults Undergoing To Hematopoietic Stem Cell Post-Transplantation

Andrea Z Pereira, MD, PhD, Silva Bernardo Juliana, RD, Silvia MF Pivocari, RD, Marcia Tanaka, RD, Barrere N Ana Paula, RD, Fabiana Lucio, RD, Claudio Galvão Castro, Jr, MD, Andreza Alice Feitosa Ribeiro, MD, PhD, Nelson Hamerschlak, MD, PhD

Blood (2013) 122 (21): 5500.

https://doi.org/10.1182/blood.V122.21.5500.5500

Published: 2013

Journal Articles

Patterns Of Non-Hematological Adverse Effects In Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Treated With Ponatinib – Experience At a Single Institution

Preetesh Jain, MD, DM, PhD, Hagop M. Kantarjian, MD, Carlos Guillermo Romo, MD, Alfonso Quintas-Cardama, MD, Elias Jabbour, MD, Marylou Cardenas-Turanzas, MD, Dr PH, Sherry Pierce, Mary Joy Liboon, Evguenia Gachimova, Tapan M. Kadia, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Susan O'Brien, MD, Jorge E. Cortes, MD

Blood (2013) 122 (21): 4019.

https://doi.org/10.1182/blood.V122.21.4019.4019

Published: 2013

Journal Articles

Long-Term Health Related Quality Of Life and Symptom Burden In Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid (ATRA) and Chemotherapy

Blood (2013) 122 (21): 770.

https://doi.org/10.1182/blood.V122.21.770.770

Published: 2013

NARROW

A Pilot Study of Exjade (Deferasirox) As Monotherapy in Higher Risk MDS or Acute Myeloid Leukemia

Combined Modality Low-Dose Radiation Therapy (2 Gy x 2) and Single-Agent Rituximab Immunotherapy in the Treatment of Indolent Non-Hodgkin Lymphoma

The Lysine-Specific Demethylase 1 (LSD1) Inhibitor Tranylcypromine (TCP) in Combination with ATRA Is Tolerable and Has Anti-Leukemic Activity in Adult Patients with Relapsed/Refractory AML and MDS

Longitudinal Sensitivity of the MD Anderson Symptom Inventory for Acute Myeloid Leukemia

Patient-Reported and Neurocognitive Outcomes in Patients Treated with Axicabtagene Ciloleucel

Safety and Tolerability of PF-04447943 across a Clinical Trial Program Including 277 Patients

Long-Term Morbidity Associated with Chronic Graft Vs. Host Disease (cGvHD) - a Blood or Marrow Transplant Survivor Study (BMTSS)

Idiopathic Hemochromatosis Presenting As a Sicca Syndrome. A Case Report and Review of the Literature

Symptom Burden of Busulfan and Melphalan Versus Melphalan Alone for Multiple Myeloma

A Drug-Drug Interaction Study of Ibrutinib with Moderate and Strong CYP3A Inhibitors in Patients with B-Cell Malignancy

Challenges of Assessing Symptom Burden in Patients with Haematological Malignancies

A Randomized Phase 2 Placebo Controlled Trial of Clobetasol Rinse for Treatment of Oral Chronic Graft-Versus-Host Disease

Symptom Burden, Quality of Life, and Distress in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy: Results of a Prospective Electronic Patient-Reported Outcomes Study

Phase 1b/2 Study of the Efficacy and Safety of Sonidegib (LDE225) in Combination with Ruxolitinib (INC424) in Patients with Myelofibrosis

A Patient-Reported Outcome Measure for Symptoms and Symptom Burden of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Retrospective Analysis to Correlate Impact of Symptom Burden and Quality of Life to Treatment Outcome with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Chronic Phase

Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Zinc Deficiency In Patients Adults Undergoing To Hematopoietic Stem Cell Post-Transplantation

Patterns Of Non-Hematological Adverse Effects In Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Treated With Ponatinib – Experience At a Single Institution

Long-Term Health Related Quality Of Life and Symptom Burden In Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid (ATRA) and Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only